Strategic Management
| strategic management report on glaxosmithkline(GSK) |
Table of Contents Letter of Acknowledgement 4 Executive Summary 5 INTRODUCTION 6 VISION STATEMENT: 6 MISSION STATEMENT: 7 GSK PAKISTAN: 7 COMPANY’S PRODUCTS 9 GSK VALUES: 10 GSK ETHICS: 11 GSK BEHAVIOURS: 11 GSK CONSUMER HEALTH CARE SEGMENT 13 Supply chain activities: 14 Marketing technique: 14 BCG MATRIX 16 Internal Factors Evaluation (IFE): 19 Strengths: 19 Weaknesses: 19 External Factors Evaluation (EFE): 20 Opportunities 20 Threats 21 THE INTERNAL-EXTERNAL (IE) MATRIX 24 Current strategy of the company 25 CPM (COMPETITIVE PROFILE MATRIX) 26 INTERPRETATION OF CPM MATRIX: 26 Financial analysis 29 Ratios 29 Current Ratio: 30 Acid Test Ratio: 30 Gross Profit: 31 Net Profit Margin: 32 Return On Equity: 33 Total asset turnover: 34 Earnings per share: 35 Other Important Financial Data 36 Conclusion 37 Appendix 38
Letter of Acknowledgement
Institute of Business Management
Korangi Creek, Karachi-75190, Pakistan
UAN (9221)111-002-004, Fax: (9221) 509-0968 www.iobm.edu.pk April 24, 2012
Dear Reader,
It is an honor for us to prepare the report on “GlaxoSmithKline” which was assigned to us by our teacher Sir Abdul Qadir Molvi. We would like to thank him for providing us information and guidance throughout our report in order to materialize our content for the report.
It was a pleasure creating such a report, on a topic so relevant, informative and insightful.
Thanking You.
Danish Parvez
Ahmed Saeed Khan
Chandni Kumari
Anum Ali Junejo
Executive Summary
This is a research on GlaxoSmithKline a pharmaceutical concern has been conducted to primarily understand two aspects. First is to comprehend the current strategy of the company and second is to suggest an apt strategy to the company after analyzing the conditions of the pharmaceutical industry and the political, social and legal environment at large. The report would
Table of Contents Letter of Acknowledgement 4 Executive Summary 5 INTRODUCTION 6 VISION STATEMENT: 6 MISSION STATEMENT: 7 GSK PAKISTAN: 7 COMPANY’S PRODUCTS 9 GSK VALUES: 10 GSK ETHICS: 11 GSK BEHAVIOURS: 11 GSK CONSUMER HEALTH CARE SEGMENT 13 Supply chain activities: 14 Marketing technique: 14 BCG MATRIX 16 Internal Factors Evaluation (IFE): 19 Strengths: 19 Weaknesses: 19 External Factors Evaluation (EFE): 20 Opportunities 20 Threats 21 THE INTERNAL-EXTERNAL (IE) MATRIX 24 Current strategy of the company 25 CPM (COMPETITIVE PROFILE MATRIX) 26 INTERPRETATION OF CPM MATRIX: 26 Financial analysis 29 Ratios 29 Current Ratio: 30 Acid Test Ratio: 30 Gross Profit: 31 Net Profit Margin: 32 Return On Equity: 33 Total asset turnover: 34 Earnings per share: 35 Other Important Financial Data 36 Conclusion 37 Appendix 38
Letter of Acknowledgement
Institute of Business Management
Korangi Creek, Karachi-75190, Pakistan
UAN (9221)111-002-004, Fax: (9221) 509-0968 www.iobm.edu.pk April 24, 2012
Dear Reader,
It is an honor for us to prepare the report on “GlaxoSmithKline” which was assigned to us by our teacher Sir Abdul Qadir Molvi. We would like to thank him for providing us information and guidance throughout our report in order to materialize our content for the report.
It was a pleasure creating such a report, on a topic so relevant, informative and insightful.
Thanking You.
Danish Parvez
Ahmed Saeed Khan
Chandni Kumari
Anum Ali Junejo
Executive Summary
This is a research on GlaxoSmithKline a pharmaceutical concern has been conducted to primarily understand two aspects. First is to comprehend the current strategy of the company and second is to suggest an apt strategy to the company after analyzing the conditions of the pharmaceutical industry and the political, social and legal environment at large. The report would